Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies.
Anamaria JurcauAurel SimionPublished in: International journal of molecular sciences (2021)
Its increasing incidence has led stroke to be the second leading cause of death worldwide. Despite significant advances in recanalization strategies, patients are still at risk for ischemia/reperfusion injuries in this pathophysiology, in which neuroinflammation is significantly involved. Research has shown that in the acute phase, neuroinflammatory cascades lead to apoptosis, disruption of the blood-brain barrier, cerebral edema, and hemorrhagic transformation, while in later stages, these pathways support tissue repair and functional recovery. The present review discusses the various cell types and the mechanisms through which neuroinflammation contributes to parenchymal injury and tissue repair, as well as therapeutic attempts made in vitro, in animal experiments, and in clinical trials which target neuroinflammation, highlighting future therapeutic perspectives.
Keyphrases
- cerebral ischemia
- subarachnoid hemorrhage
- blood brain barrier
- brain injury
- clinical trial
- end stage renal disease
- lipopolysaccharide induced
- chronic kidney disease
- lps induced
- traumatic brain injury
- newly diagnosed
- oxidative stress
- cognitive impairment
- endoplasmic reticulum stress
- risk factors
- prognostic factors
- cell death
- stem cells
- cell therapy
- patient reported outcomes
- bone marrow
- current status
- cell proliferation